HemaSphere
(Jun 2022)
P390: ACUTE MYELOID LEUKEMIA SUPPRESSION BY PALBOCICLIB AND PONATINIB IN PATIENT-DERIVED XENOGRAFT
- D. Busa,
- M. Culen,
- T. Loja,
- I. Jeziskova,
- A. Folta,
- J. Mayer
Affiliations
- D. Busa
- 1 Department of Internal Medicine - Hematology and Oncology, Masaryk University
- M. Culen
- 1 Department of Internal Medicine - Hematology and Oncology, Masaryk University
- T. Loja
- 3 Central European Institute of Technology, Brno, Czechia
- I. Jeziskova
- 1 Department of Internal Medicine - Hematology and Oncology, Masaryk University
- A. Folta
- 1 Department of Internal Medicine - Hematology and Oncology, Masaryk University
- J. Mayer
- 1 Department of Internal Medicine - Hematology and Oncology, Masaryk University
- DOI
-
https://doi.org/10.1097/01.HS9.0000844448.69756.43
- Journal volume & issue
-
Vol. 6
pp.
290
– 291
WeChat QR code